|
SOAT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.136300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.100400E-02 |
| Normal-vs-Stage2 |
3.223600E-02 |
| Normal-vs-Stage3 |
1.045230E-01 |
| Normal-vs-Stage4 |
3.082400E-02 |
| Stage1-vs-Stage2 |
1.480960E-01 |
| Stage1-vs-Stage3 |
6.777600E-01 |
| Stage1-vs-Stage4 |
2.824800E-01 |
| Stage2-vs-Stage3 |
2.409400E-01 |
| Stage2-vs-Stage4 |
5.089600E-01 |
| Stage3-vs-Stage4 |
5.788200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.136580E-03 |
| Normal-vs-AfricanAmerican |
3.249200E-01 |
| Normal-vs-Asian |
8.799900E-02 |
| Caucasian-vs-AfricanAmerican |
1.899790E-03 |
| Caucasian-vs-Asian |
2.842400E-02 |
| AfricanAmerican-vs-Asian |
6.839900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.816200E-04 |
| Normal-vs-Female |
3.316800E-01 |
| Male-vs-Female |
2.271900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.726000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.130390E-02 |
| Normal-vs-Age(61-80Yrs) |
7.215800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.159000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.574400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.002800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.031000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.223000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.320200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.893400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.007600E-01 |
| Normal-vs-Grade 2 |
5.776300E-02 |
| Normal-vs-Grade 3 |
7.436100E-02 |
| Normal-vs-Grade 4 |
2.143400E-03 |
| Grade 1-vs-Grade 2 |
7.347900E-02 |
| Grade 1-vs-Grade 3 |
9.114400E-02 |
| Grade 1-vs-Grade 4 |
2.864200E-03 |
| Grade 2-vs-Grade 3 |
8.046000E-01 |
| Grade 2-vs-Grade 4 |
3.960500E-02 |
| Grade 3-vs-Grade 4 |
2.592000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.538400E-01 |
| Normal-vs-ccB subtype |
1.51693000000064E-05 |
| ccA subtype-vs-ccB subtype |
4.18189999999985E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.140900E-03 |
| Normal-vs-N1 |
5.786200E-02 |
| N0-vs-N1 |
1.691440E-01 |
|
|
